Literature DB >> 28954101

Molecular basis of basal cell carcinoma.

Erik Montagna1, Otávio Sérgio Lopes2,3.   

Abstract

Basal cell carcinoma is the most common cancer, presenting low mortality but high morbidity, and it has as risk factor exposure to sunlight, especially UVB spectrum. The most important constitutional risk factors for basal cell carcinoma development are clear phototypes (I and II, Fitzpatrick classification), family history of basal cell carcinoma (30-60%), freckles in childhood, eyes and light hair. The environmental risk factor better established is exposure to ultraviolet radiation. However, different solar exposure scenarios probably are independent risk factors for certain clinical and histological types, topographies and prognosis of this tumor, and focus of controversy among researchers. Studies confirm that changes in cellular genes Hedgehog signaling pathway are associated with the development of basal cell carcinoma. The cellular Hedgehog signaling pathway is activated in organogenesis, but is altered in various types of tumors.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28954101      PMCID: PMC5595599          DOI: 10.1590/abd1806-4841.20176544

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  53 in total

1.  [Risk factors for basal cell carcinoma. Case-control study in Cordoba].

Authors:  Alejandro Ruiz Lascano; Raquel Kuznitzky; Iliana Garay; Cristina Ducasse; Ricardo Albertini
Journal:  Medicina (B Aires)       Date:  2005       Impact factor: 0.653

2.  Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity.

Authors:  Minrui Liang; Jiaoyan Lv; Haiyan Chu; Jiucun Wang; Xiangjun Chen; Xiaoxia Zhu; Yu Xue; Ming Guan; Hejian Zou
Journal:  J Dermatol Sci       Date:  2014-09-07       Impact factor: 4.563

Review 3.  Epidemiology of basal cell carcinoma.

Authors:  Valquiria Pessoa Chinem; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2011 Mar-Apr       Impact factor: 1.896

Review 4.  Genetics and risk factors for basal cell carcinoma.

Authors:  V Madan; P Hoban; R C Strange; A A Fryer; J T Lear
Journal:  Br J Dermatol       Date:  2006-05       Impact factor: 9.302

Review 5.  Emerging drugs and combination strategies for basal cell carcinoma.

Authors:  Jil Dreier; Reinhard Dummer; Lea Felderer; Mirjam Nägeli; Sharon Gobbi; Rainer Kunstfeld
Journal:  Expert Opin Emerg Drugs       Date:  2014-04-29       Impact factor: 4.191

Review 6.  Review of the hair follicle origin hypothesis for basal cell carcinoma.

Authors:  Jeff Donovan
Journal:  Dermatol Surg       Date:  2009-06-02       Impact factor: 3.398

Review 7.  Epidemiology and aetiology of basal cell carcinoma.

Authors:  J Roewert-Huber; B Lange-Asschenfeldt; E Stockfleth; H Kerl
Journal:  Br J Dermatol       Date:  2007-12       Impact factor: 9.302

8.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

Review 9.  Why classify basal cell carcinomas?

Authors:  J J Rippey
Journal:  Histopathology       Date:  1998-05       Impact factor: 5.087

Review 10.  Communicating with Hedgehogs.

Authors:  Joan E Hooper; Matthew P Scott
Journal:  Nat Rev Mol Cell Biol       Date:  2005-04       Impact factor: 94.444

View more
  1 in total

Review 1.  Non-melanoma skin cancers: physio-pathology and role of lipid delivery systems in new chemotherapeutic treatments.

Authors:  Eliana B Souto; Raquel da Ana; Vânia Vieira; Joana F Fangueiro; João Dias-Ferreira; Amanda Cano; Aleksandra Zielińska; Amélia M Silva; Rafał Staszewski; Jacek Karczewski
Journal:  Neoplasia       Date:  2022-05-29       Impact factor: 6.218

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.